Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
28.01
-0.50 (-1.77%)
At close: Jul 6, 2026, 4:00 PM EDT
27.65
-0.36 (-1.29%)
After-hours: Jul 6, 2026, 7:55 PM EDT

Genmab Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Genmab stock has a consensus rating of "Strong Buy" and an average price target of $36.82. The average 1-year stock price forecast is 31.45% higher than the current stock price, while the lowest is $32 (+14.24%) and the highest is $41.5 (+48.16%).

Price Target: $36.82 (+31.45%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$32$36.82$38$41.5
Change+14.24%+31.45%+35.67%+48.16%

Analyst Ratings

The average analyst rating for Genmab stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy689999
Buy000000
Hold332222
Sell000000
Strong Sell000000
Total91111111111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$38$40
BuyReiterates$38$40+42.81%Jul 2, 2026
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 30, 2026
Guggenheim
Guggenheim
Buy
Maintains
$40
BuyMaintains$40+42.81%Jun 30, 2026
Wells Fargo
Wells Fargo
Buy
Reiterates
$40
BuyReiterates$40+42.81%Jun 30, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 30, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
4.39B
from 3.72B
Increased by 18.02%
Revenue Next Year
5.14B
from 4.39B
Increased by 17.03%
EPS This Year
1.17
from 1.77
Decreased by -33.89%
EPS Next Year
1.68
from 1.17
Increased by 43.23%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Jan 1, 2024Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.29B2.08B2.39B3.12B3.72B4.39B
Revenue Growth
-22.52%61.88%14.68%30.59%19.19%18.02%
Gross Profit
1.29B2.08B2.36B2.98B3.48B4.11B
Gross Margin
100.00%100.00%98.62%95.42%93.60%93.53%
Operating Income
451.68M900.43M772.00M1.02B1.25B1.18B
Net Income
452.29M783.33M631.00M1.13B963.00M754.06M
EPS
----1.771.17
EPS Growth
-----10.69%-33.89%
Forward PE
-----23.91
Free Cash Flow
259.80M305.10M777.92M915.13M1.07B974.38M
No. Analysts
-----22
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High4.7B
Avg4.4B
Low4.2B

Revenue Growth

Revenue Growth202620272028
High
26.5%
Avg
18.0%
Low
13.6%

EPS Forecast

EPS202620272028
High1.71
Avg1.17
Low0.95

EPS Growth

EPS Growth202620272028
High
-3.3%
Avg
-33.9%
Low
-46.3%